MediPharm Labs Generates $32 Million Revenue in Q4

MediPharm Labs Reports Fourth Quarter and Full Year 2019 Results 2019 Revenue $129 Million, Adjusted EBITDA1 $25 Million Q4 2019 Revenue $32 Million, Adjusted EBITDA1 $3 Million Year-end Cash and Equivalents...

- March 30th, 2020 at 7:40 am

MediPharm Labs Sues Unnamed LP for $9.8 Million Seeking Payment for Cannabis Oil Agreement

MediPharm Labs Files Statement of Claim BARRIE, Ontario, Jan. 24, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) today...

- January 24th, 2020 at 5:18 pm

MediPharm Labs Q3 Revenue Increases 38% From Q2 to $43.4 Million

MediPharm Labs Reports Strong, Profitable 2019 Third Quarter While Investing for Future Global Advantage Revenue $43.4 million, adjusted EBITDA $10.1 million BARRIE, Ontario, Nov. 12, 2019 (GLOBE NEWSWIRE) —...

- November 12th, 2019 at 6:13 am

MediPharm Labs Submits Application to List on NASDAQ

BARRIE, Ontario, Nov. 05, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation and...

- November 5th, 2019 at 7:24 am

MediPharm Labs Closes New $38.7 Million Upsized Credit Facility with a Top 5 Canadian Schedule 1 Bank to Support Growth

TORONTO, Oct. 10, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction,...

- October 10th, 2019 at 7:53 am

MediPharm Labs and TerrAscend Enter Major Private Label Concentrate Supply Agreement With Potential Value Up to $192 Million

MediPharm Labs to supply TerrAscend with large volumes of high-quality CBD and THC distillate Multi-Year supply agreement to support TerrAscend’s roll out of Canadian Cannabis 2.0 derivative products TORONTO,...

- September 25th, 2019 at 6:14 am

MediPharm Labs Boosts Q2 Revenue 43% Sequentially to $31.5 Million

MediPharm Labs Reports Strong, Profitable Second Quarter Results Q2 2019 Revenue of $31.5 Million, Adjusted EBITDA of $7.7 Million, Net Income before tax of $4.1 Million TORONTO, Aug. 12,...

- August 12th, 2019 at 5:20 pm

MediPharm Labs Conditionally Approved to Graduate to the TSX

TORONTO, July 18, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction,...

- July 18th, 2019 at 7:34 am

MediPharm Labs Announces Application to Upgrade Listing to the Toronto Stock Exchange

TORONTO, June 18, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction,...

- June 18th, 2019 at 7:18 am

MediPharm Labs Announces Closing of $75 Million Bought Deal Financing

TORONTO, June 17, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a leader in specialized, research-driven cannabis extraction and...

- June 17th, 2019 at 9:04 am

MediPharm Labs Raises $60 Million Selling Stock at $5.55

MediPharm Labs Announces $60 Million Bought Deal Equity Financing TORONTO, May 28, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”),...

- May 28th, 2019 at 4:59 pm

MediPharm Labs to Provide Cronos Group Cannabis Extracts For a Minimum of $30 Million

Cronos Group and MediPharm Labs Enter $30 Million Multi-Year Private Label Cannabis Concentrate Supply Agreement with Potential to Increase to $60 Million Cronos Group and MediPharm Labs Enter Additional...

- May 14th, 2019 at 7:44 am

MediPharm Labs Q1 Revenue Jumps 115% from Prior Quarter to $22 Million

MediPharm Labs Announces Q1 2019 Revenue of $22 Million and Adjusted EBITDA of $4.3 Million TORONTO, May 10, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF)...

- May 10th, 2019 at 7:37 am

MediPharm Labs Appoints Former Johnson & Johnson Group Product Director as Chief Strategy Officer

New Pharma Executive Position Created to Advance Corporate Strategy, Global Growth and Strategic Partnerships TORONTO, April 29, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MEDIF) (FSE:...

- April 29th, 2019 at 8:46 am

Cannabis Extractor MediPharm Labs Generates Q4 Revenue of $10.2 Million

MediPharm Labs Reports Q4 2018 Revenue of $10.2 Million and Adjusted EBITDA of $2.1 Million TORONTO, April 03, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF)...

- April 3rd, 2019 at 7:17 am

MediPharm Labs Signs First International Private Label Sale Agreement With AusCann for Cannabis Oil Export to Australia

MediPharm Labs Becomes First Extraction Only Licensed Producer to Begin Global Export TORONTO, Feb. 21, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE:MLZ) (“MediPharm Labs”),...

- February 21st, 2019 at 7:18 am

Cannabis Oil Supplier MediPharm Labs Signs $35 Million Minimum Supply Deal with Canadian Licensed Producer

  MediPharm Labs Signs $35 Million Private Label Cannabis Oil Sale Agreement with Option for Additional $13.5 Million TORONTO, Feb. 12, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV:...

- February 12th, 2019 at 6:43 am

Medipharm Labs Ships Over $10 Million of Cannabis Oil

MediPharm Labs Signs New Cannabis Oil Agreements and Completes First Shipments of Supply in December TORONTO, Jan. 16, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS; OTCQB: MLCPF)...

- January 16th, 2019 at 1:57 pm

MediPharm Labs Adds TerrAscend as Cannabis Extraction Customer

MediPharm Labs Signs Large Multi-Year Cannabis Extraction Agreement With TerrAscend Marking Strong Start to 2019 TORONTO, Jan. 08, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS; OTCQB: MLCPF)...

- January 8th, 2019 at 7:42 am

MediPharm Labs Corp. Receives Sales Licence from Health Canada

TORONTO, Nov. 12, 2018 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (“MediPharm Labs” or the “Company”) (TSXV: LABS) is pleased to announce that its wholly-owned subsidiary, MediPharm Labs Inc., has...

- November 12th, 2018 at 11:38 am

Cannabis Extracts Producer MediPharm Labs Debuts on the TSX Venture

MediPharm Labs Corp. (TSXV: LABS) (Formerly POCML 4 Inc.) Provides Corporate Update Upon Commencement of Trading on the TSXV TORONTO, Oct. 04, 2018 (GLOBE NEWSWIRE) — MediPharm Labs Corp....

- October 4th, 2018 at 9:15 am

Cannabis Extraction LP MediPharm Labs to Begin Trading Next Week

POCML 4 Inc. Files Filing Statement in Connection With Proposed Qualifying Transaction With MediPharm Labs Inc.; Expects to Commence Trading on TSXV Under the Ticker Symbol “LABS” on or...

- September 25th, 2018 at 5:44 pm

Extraction Focused Canadian LP MediPharm Labs to Go Public

POCML 4 Inc. Agrees to Qualifying Transaction With MediPharm Labs Inc. TORONTO, May 15, 2018 (GLOBE NEWSWIRE) — POCML 4 Inc. (TSXV:POCM) (“POCML”) announces that it has signed a...

- May 15th, 2018 at 4:40 pm

MediPharm Labs First Canadian LP Licensed Exclusively for Extraction

MediPharm Labs Receives Cannabis Oil Production License BARRIE, Ontario, April 05, 2018 (GLOBE NEWSWIRE) — MediPharm Labs Inc. (“MediPharm”) is pleased to announce today that it has received its...

- April 5th, 2018 at 8:59 am